Literature DB >> 14564542

Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?

S Ranganathan1, S Webber, S Ahuja, R Jaffe.   

Abstract

Epstein-Barr virus (EBV)-mediated lymphoid proliferations occur in patients who are immunocompromised and are reported following bone marrow or solid organ transplantation. Most post-transplant lymphoproliferative disorders (PTLD) are polymorphic in appearance; some are monomorphic and can resemble conventional malignant lymphomas. PTLD that resembles Hodgkin lymphoma has been reported infrequently. We herein report seven cases of PTLD that have large numbers of Reed-Sternberg-like (RS-like) cells and highlight differences in the phenotype of these cases that may distinguish Hodgkin-like PTLD (HL-PTLD) from true Hodgkin lymphoma/disease (HD). All patients were in the second decade of life and were 8 months to 13 years following transplant. HL-PTLD involves lymph nodes that contain a mixed population of small to intermediate-sized lymphocytes with large mononuclear and occasionally binucleate RS-like cells. The large cells of HL-PTLD are pleomorphic B cells that react strongly for CD20 and/or CD79a, express CD30, but are usually negative for CD15 and have few mitoses. They are positive for EBV early RNA (EBER) using an EBER-1 probe, as are some of the background small lymphocytes. A single case of true Hodgkin lymphoma has highly atypical RS-like cells that contain numerous mitoses, does not have CD20 or CD79a reactivity, has CD15 and CD30 staining, and the EBER-1 probe is confined to the large cells only. All patients were managed by withdrawal of immunosuppression and variably treated with either antiviral or anti-CD20 monoclonal antibody, or with chemotherapy. A unique instance of evolution from a HL-PTLD to true HD is also illustrated. In conclusion, HL-PTLD and HD appear to be two related but immunophenotypically and biologically distinct forms of lymphoproliferation in post-transplant patients and may require different protocols for their management. Copyright 2004 Society for Pediatric Pathology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14564542     DOI: 10.1007/s10024-003-9877-y

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  4 in total

1.  Hodgkin's lymphoma developed after autologous stem cell transplantation for multiple myeloma: transformation or coincidental appearance?

Authors:  Istvan Kulcsar; Antonia Szanto; Laszlo Varoczy; Gabor Mehes; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2011-11-24       Impact factor: 3.201

2.  A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

Authors:  Omar S Salh; Omar N Nadhem; Sanket R Thakore; Ruba A Halloush; Faisal A Khasawneh
Journal:  Can Respir J       Date:  2015 May-Jun       Impact factor: 2.409

3.  Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.

Authors:  Aaron S Rosenberg; Andreas K Klein; Robin Ruthazer; Andrew M Evens
Journal:  Am J Hematol       Date:  2016-04-26       Impact factor: 10.047

4.  Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.

Authors:  Taro Mohri; Yoshihiro Ikura; Asako Hirakoso; Masashi Okamoto; Masakatsu Hishizawa; Akifumi Takaori-Kondo; Seiichi Kato; Shigeo Nakamura; Kai Yoshimura; Hidetoshi Okabe; Yasuhiro Iwai
Journal:  Int J Hematol       Date:  2018-01-29       Impact factor: 2.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.